证券代码：688272 证券简称：富吉瑞 公告编号：2025-030 北京富吉瑞光电科技股份有限公司 特定股东减持股份结果公告 公司于2025年3月25日披露《特定股东减持股份计划公告》，苏州空空拟通过竞价交易、大宗交易方式 减持股份数量合计不超过1,215,618股，即不超过公司总股本的1.60%；苏州兆戎拟通过竞价交易、大宗 交易方式减持股份数量合计不超过1,463,490股，即不超过公司总股本的1.93%；上海兆韧拟通过竞价交 易、大宗交易方式减持股份数量合计不超过289,200股，即不超过公司总股本的0.38%，自减持计划公告 披露之日起3个交易日后的3个月内进行。 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 股东持股的基本情况 本减持计划实施前，北京富吉瑞光电科技股份有限公司（以下简称"富吉瑞"或"公司"）股东苏州空空创 业投资合伙企业（有限合伙）（以下简称"苏州空空"）持有公司股份1,215,618股，占公司总股本的 1.60%；苏州兆戎空天创业投资合伙企业（有限合伙）（以下简 ...

Group 1 - The S&P 500 futures rose by 0.36% at the end of trading on Monday, June 30 [1] - The Dow Jones futures increased by 0.51% [1] - The Nasdaq 100 futures gained 0.53% [1] Group 2 - The Russell 2000 futures saw a slight increase of 0.03% [2]

Core Insights - The article emphasizes the focus on growth and momentum stocks that are reasonably priced and expected to outperform the market in the long term [1] - It highlights a significant investment opportunity, noting that the S&P 500 increased by 367% and the Nasdaq by 685% from 2009 to 2019, following a recommendation to buy at the financial crisis's bottom in March 2009 [1] Investment Strategy - The investment strategy involves long-term investment in quality stocks, with the use of options to enhance returns [1] - The goal is to assist investors in making money through investments in high-quality growth stocks [1]

Core Points - Finning International Inc. has completed the sale of 100% of its mobile on-site refueling business, 4Refuel, to affiliates of H.I.G. Capital [1] - The company also finalized the sale of Compression Technology Corporation (ComTech) to a third party on May 15, 2025 [2] - These transactions are part of Finning's strategy to simplify its business and focus on core dealership operations, aiming to unlock invested capital and enhance pro-forma return on invested capital [3] Company Overview - Finning is recognized as the world's largest Caterpillar dealer, providing equipment, parts, services, and performance solutions across various regions including Western Canada, Chile, Argentina, Bolivia, the UK, and Ireland [4]

Group 1 - The core viewpoint indicates that gold and silver prices have shown positive performance in June and the second quarter, with gold rising approximately 0.28% in June and about 7.29% in Q2 [1] - COMEX gold futures increased by 0.93%, reaching $3318.30 per ounce, with a June increase of 0.10% and a Q2 increase of approximately 5.67% [1] - The Philadelphia Gold and Silver Index rose by 2.40% to 205.64 points, with a June increase of 6.98% and a Q2 increase of 17.00% [2] Group 2 - Spot silver prices increased by 0.29%, reaching $36.0933 per ounce, with a June increase of 9.47% and a Q2 increase of approximately 5.49% [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600828 证券简称：茂业商业公告编号：临2025-033号 茂业商业股份有限公司 关于控股股东股份办理质押及解除质押的公告 重要内容提示： ● 茂业商业股份有限公司（以下简称"茂业商业"、"公司"）控股股东深圳茂业商厦有限公司（以下简 称"茂业商厦"）及其一致行动人合计持有公司股份1,497,380,497 股，占上市公司总股本的86.45%。茂业 商厦及其一致行动人持有公司股份累计质押数量（本次办理质押及解押后）为408,380,000股，占其所持 有公司股份总额的29.15%，占公司总股本的23.58%。 一、股份质押情况 接控股股东茂业商厦通知，茂业商厦向上海海通证券资产管理有限公司（以下简称"海通资管"）申请续 贷并签订了《最高额抵押合同》，茂业商厦将其所持有的茂业商业无限售流通股份89,200,000股质押给 海通资管,用于日常经营周转。该股票质押登记手续于近日通过中国证券登记结算有限公司办理。本次 质押基本情况如下： 1、本次股份质押基本情况 ■ 2、本次质押股份未被用作重大资产重组业绩补偿等事项的担保或其他保障用途。 3、控股股东累 ...

一、合同主要内容 河北省邯郸市百万蛋鸡农业科技产业园全过程工程咨询服务合同金额为17,544.03万元，该项目位于河北 省邯郸市，项目内容为咨询人向委托人提供全过程工程咨询服务，包括：项目管理、工程勘察、工程规 划及设计、工程监理、全过程造价咨询、招标代理、融资咨询和其他专项评价咨询。其中，京兴国际 （联合体牵头人）、中国中元和中元长春主要承担项目管理、工程监理、其他专项评价咨询，以及工程 规划及设计、工程勘察等工作，所承担的合同工作量对应合同金额为13,105.39万元（具体金额根据实际 完成的工作量据实计算）。服务期限为合同签订之日至该项目完成竣工验收和工程结算之日止。 二、交易对方情况介绍 河北省邯郸市百万蛋鸡农业科技产业园全过程工程咨询服务合同的交易对方为深圳宸可投资控股有限公 司，注册地址为深圳市宝安区新安街道海旺社区宝兴路88号星通大厦1507。该公司成立于2023年，为国 内领先的大型蛋品全产业链集团广东宸可资本控股集团有限公司的全资子公司。深圳宸可投资控股有限 公司与公司不存在关联关系，上一会计年度未与公司发生类似业务。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 ...

自创立以来，微电生理围绕三维心脏电生理手术技术进行系统性的产品布局和应用拓展，形成了以图像 导航、精密器械及能量治疗为核心的三大技术平台。2022年8月，微电生理在科创板的成功上市，为这 家深耕电生理领域的企业注入了强劲的发展动能。 孙毅勇表示，资本的注入让公司得以在高投入、长周期的创新赛道上保持战略定力，"研发是我们的生 命线，上市为这条生命线提供了坚实的后盾，保障了新产品管线的快速推进。"2024年，公司研发投入 占营业收入比例近25%，处于行业领先水平。 借资本，强创新 产能升级与全球化布局的资金需求也在上市后得到有效满足。随着全国性集采政策的推进，电生理产品 市场需求快速释放，微电生理加速推进生产场地扩建与智能化产线改造，以应对集采带来的规模化销售 挑战。 "上市不仅解决了资金问题，更重要的是提升了企业的资源整合能力。"孙毅勇指出，资本市场的认可让 企业在供应链管理、国际合作等方面获得了更多话语权，为后续的全球化竞争奠定了基础。 ● 本报记者 罗京 依托资本引擎加速创新，借势国家集采政策实现市场份额跃升，科创板上市公司微电生理正将目光锁定 全球市场，开启国际化新征程。"我们希望用中国创新为全球心律失常 ...

Core Viewpoint - The enthusiasm for stock buybacks in the A-share market remains strong, with several leading companies, such as China Communications Construction Company (CCCC), planning significant buybacks to enhance shareholder value and investor confidence [1][2]. Group 1: Buyback Plans and Amounts - CCCC plans to repurchase A-shares with a total fund of no less than 5 billion yuan and not exceeding 10 billion yuan, with a buyback price capped at 13.58 yuan per share [1]. - Shengxin Lithium Energy announced a buyback plan with a total fund of no less than 4 million yuan and not exceeding 5 million yuan, with a buyback price capped at 17.75 yuan per share, to be executed within three months [2]. - Shaanxi Jinye's actual controller proposed a buyback with a total fund of no less than 40 million yuan and not exceeding 70 million yuan [2]. Group 2: Implementation of Buyback Plans - Unisplendour announced its first buyback on June 27, repurchasing approximately 775,500 shares at a total cost of about 49.62 million yuan, with prices ranging from 63.67 to 64.28 yuan per share [3][4]. - Shengmei Shanghai executed its first buyback on June 27, repurchasing 443,400 shares at a total cost of approximately 50.01 million yuan, with prices ranging from 110.81 to 115.49 yuan per share [4][5]. Group 3: Financing for Buybacks - A total of 674 A-share companies or significant shareholders have obtained buyback financing loans amounting to approximately 134.6 billion yuan since October 2024 [1][6]. - Haiou Co. received a commitment letter for a buyback loan not exceeding 108 million yuan from a financial institution [6]. - Shanying International obtained a commitment for a buyback loan not exceeding 300 million yuan, with a loan term of 36 months [6]. Group 4: Market Insights - The use of buyback financing loans is seen as a low-cost funding option for companies and shareholders, facilitating more effective implementation of buyback and increase plans [7].

Core Insights - Dong'e Ejiao is undergoing a significant digital and intelligent transformation, investing 24.48 million yuan in 2024 to integrate traditional Chinese medicine with modern digital technology [1] - The company has implemented a fully automated production line for traditional Chinese medicine oral liquids, enhancing operational efficiency and reducing labor requirements [1][2] - The introduction of AI and IoT technologies has improved quality control and operational management across various processes, including raw material supply and product development [2][3] Digital Transformation - Dong'e Ejiao's investment in digitalization includes the development of an AI-based quality control system and IoT-enabled environmental monitoring, enhancing overall production capabilities [2] - The company has achieved a raw material loss rate of 0.8% and a 30% increase in per capita output value through intelligent production processes [2] Supply Chain Optimization - The establishment of a smart supply chain system allows for precise forecasting and inventory management, reducing average inventory turnover days from 84 to 30 and decreasing obsolete materials by 50% [3] - The integration of sales and production planning has improved plan accuracy by 30%, with key product plan accuracy exceeding 90% [3] R&D and Product Development - Dong'e Ejiao has developed a product lifecycle management platform that standardizes and modularizes product data management, facilitating collaborative R&D and shortening product development cycles [3] - The company aims to address challenges in traditional Chinese medicine production, such as standardization and quality control, by creating a comprehensive digital system covering the entire supply chain [3] Industry Impact - As a representative enterprise in the health supplement industry, Dong'e Ejiao is leveraging AI and digital technologies to enhance its entire value chain, from breeding and R&D to production and consumer services [4] - The company's digital transformation efforts are expected to promote the inheritance and innovation of traditional Chinese medicine culture while exploring new growth opportunities in the industry [4]